Friday's session: gap up and gap down stocks
Immuneering Corp IMRX
$5.13
▼ -3.84%
($-0.21)
Open
$5.37
Prev Close
$5.34
Day Range
$5.05 – $5.46
52W Range
$1.56 – $10.08
Market Cap
$340.90M
Beta
0.25
EPS (TTM)
$-1.17
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-30 |
| Shares Out. | 64,700,000 |
| Website | immuneering.com/ ↗ |
| Phone | 16175008080 |
Immuneering Corp is a publicly traded company under the ticker symbol IMRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-05-01)
📰 Latest News for IMRX
Crude Oil Edges Higher; US Consumer Sentiment Falls In May
Zoom Upbeat Q1 Results, Joins Lionsgate Studios, Ross Stores And Other Big Stocks Moving Higher On Friday
Immuneering Reveals 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy; Tolerability Profile Consistent With Prior Updates; Only Two Categories Of Grade 3 Or Higher Treatment-Related Adverse Events Observed In ≥10% Of Patients, Both Chemotherapy-Related
Immuneering Q1 EPS $(0.21) Beats $(0.26) Estimate
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates